ATEA PHARMACEUTICALS INITIATES FIRST-IN-HUMAN PHASE 1 CLINICAL TRIAL OF AT-587 FOR THE TREATMENT OF HEPATITIS E VIRUS

Reuters · 3d ago

Please log in to view news